| A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia (NCT04996030) | Syros Pharmaceuticals | 2021-09-17 |
| Frontline Oral Arsenic Trioxide for APL (NCT04687176) | The University of Hong Kong | 2021-01-01 |
| Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia (NCT03751917) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2020-04-14 |
| The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project (NCT04251754) | The University of Hong Kong | 2020-02-02 |
| Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia (NCT04793919) | Associazione Italiana Ematologia Oncologia Pediatrica | 2019-10-09 |
| Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia (NCT03624270) | The University of Hong Kong | 2018-08-15 |
| Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy (NCT03096496) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2017-03-27 |
| Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) (NCT02899169) | First Affiliated Hospital Xi'an Jiaotong University | 2016-09-01 |
| Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia (NCT02688140) | Technische Universität Dresden | 2016-06-01 |
| French Registry of First-line Treatment of Acute Promyelocytic Leukemia (NCT02938858) | Groupe Francophone des Myelodysplasies | 2015-10-01 |
| Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia (NCT02991066) | First Affiliated Hospital of Harbin Medical University | 2014-10-01 |
| A Safety Study of SGN-CD33A in AML Patients (NCT01902329) | Seagen Inc. | 2013-07-01 |
| Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia (NCT01910623) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2013-02-01 |
| Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL (NCT01987297) | Shanghai Jiao Tong University School of Medicine | 2012-06-01 |
| Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy (NCT01472107) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2012-03-07 |
| Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy (NCT01404949) | Memorial Sloan Kettering Cancer Center | 2011-07-01 |
| New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia (NCT00670150) | University of Southern California | 2010-05-01 |
| Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia (NCT00985530) | Northwestern University | 2009-10-01 |
| ASCT for Relapsed APL After Molecular Remission (NCT00907582) | Shanghai Jiao Tong University School of Medicine | 2009-06-01 |
| Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia (NCT01226303) | Associazione Italiana Ematologia Oncologia Pediatrica | 2009-01-01 |
| Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia (NCT00675870) | NuRx Pharmaceuticals, Inc. | 2008-04-01 |
| Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias (NCT00852709) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-09-01 |
| Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL (NCT00520208) | CytRx | 2007-09-01 |
| Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) (NCT00504764) | PETHEMA Foundation | 2007-07-01 |
| All-trans Retinoic Acid, and Arsenic +/- Idarubicin (NCT00413166) | M.D. Anderson Cancer Center | 2006-12-01 |
| Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) (NCT00408278) | PETHEMA Foundation | 2005-07-01 |
| Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (NCT00517712) | Christian Medical College, Vellore, India | 2004-06-01 |
| AIDA 2000 Guidelines (NCT01064570) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2000-05-01 |
| Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia (NCT00003861) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Treatment of Acute Promyelocytic Leukemia With All-Trans Retinoic Acid (ATRA) and Idarubicin (AIDA) (NCT00465933) | PETHEMA Foundation | 1999-03-01 |